Purdue Pharma to plead guilty and pay $8.3 billion over opioids
The settlement is likely to boost Purdue's effort to move past claims it helped spark a public-health crisis over opioids with its marketing of OxyContin.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | International Medicine & Public Health | Marketing | Oxycodone | OxyContin | Pharmaceuticals